A detailed history of Trust Investment Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Trust Investment Advisors holds 1,413 shares of ABBV stock, worth $284,295. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,413
Holding current value
$284,295
% of portfolio
0.16%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $218,718 - $255,413
1,413 New
1,413 $242,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $222,699 - $256,471
-1,540 Reduced 13.03%
10,275 $1.64 Million
Q4 2022

Feb 28, 2023

SELL
$138.31 - $165.87 $898,461 - $1.08 Million
-6,496 Reduced 35.48%
11,815 $1.91 Million
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $1.13 Million - $1.36 Million
8,172 Added 80.6%
18,311 $2.96 Million
Q3 2022

Nov 02, 2022

SELL
$134.21 - $153.93 $28,989 - $33,248
-216 Reduced 2.09%
10,139 $1.36 Million
Q2 2022

Jul 22, 2022

SELL
$137.62 - $174.96 $688 - $874
-5 Reduced 0.05%
10,355 $1.59 Million
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $15,045 - $18,667
114 Added 1.11%
10,360 $1.68 Million
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $11,602 - $14,680
108 Added 1.07%
10,246 $1.39 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $27,557 - $31,282
-259 Reduced 2.49%
10,138 $1.09 Million
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $54,603 - $60,831
519 Added 5.25%
10,397 $1.17 Million
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $135,547 - $149,221
1,325 Added 15.49%
9,878 $1.07 Million
Q4 2020

Feb 05, 2021

BUY
$80.49 - $108.67 $688,430 - $929,454
8,553 New
8,553 $916,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Trust Investment Advisors Portfolio

Follow Trust Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Trust Investment Advisors with notifications on news.